Active and passive smoking, IL6, ESR1, and breast cancer risk

[1]  T. Byers,et al.  IL6, Aspirin, Nonsteroidal Anti-inflammatory Drugs, and Breast Cancer Risk in Women Living in the Southwestern United States , 2007, Cancer Epidemiology Biomarkers & Prevention.

[2]  R. Wolff,et al.  ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States , 2007, Breast Cancer Research and Treatment.

[3]  R. Wolff,et al.  Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women , 2007, Breast Cancer Research and Treatment.

[4]  Heike Knüpfer,et al.  Significance of interleukin-6 (IL-6) in breast cancer (review) , 2007, Breast Cancer Research and Treatment.

[5]  S. Chanock,et al.  Tobacco smoking, NAT2 acetylation genotype and breast cancer risk , 2006, International journal of cancer.

[6]  Robert C. G. Martin,et al.  Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival , 2006, Breast Cancer Research.

[7]  A. Miller,et al.  Cigarette smoking and breast cancer risk: update of a prospective cohort study , 2006, Breast Cancer Research and Treatment.

[8]  M. Goodman,et al.  Is the Association between Cigarette Smoking and Breast Cancer Modified by Genotype? A Review of Epidemiologic Studies and Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[9]  J. Cerhan,et al.  Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer. , 2005, Mayo Clinic proceedings.

[10]  S. Cummings,et al.  Association of estrogen receptor α polymorphisms with breast cancer risk in older Caucasian women , 2005 .

[11]  J. Bartlett,et al.  AKT activation predicts outcome in breast cancer patients treated with tamoxifen , 2005, The Journal of pathology.

[12]  K. Malone,et al.  The Relationship Between Various Measures of Cigarette Smoking and Risk of Breast Cancer Among Older Women 65–79 years of Age (United States) , 2005, Cancer Causes & Control.

[13]  S. Kritchevsky,et al.  Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition Cohort , 2005, Cancer Epidemiology Biomarkers & Prevention.

[14]  G. Windham,et al.  Cigarette Smoking and Effects on Hormone Function in Premenopausal Women , 2005, Environmental health perspectives.

[15]  Wanqing Wen,et al.  Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  D. Grobbee,et al.  The estrogen receptor alpha gene and breast cancer risk (The Netherlands). , 2005, Cancer causes & control : CCC.

[17]  J. Russo,et al.  Differentiation of the mammary gland and susceptibility to carcinogenesis , 2005, Breast Cancer Research and Treatment.

[18]  Bjarni V. Halldórsson,et al.  Estrogen Receptor Genotypes and Haplotypes Associated with Breast Cancer Risk , 2004, Cancer Research.

[19]  D. Bell,et al.  N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. , 2004, Cancer detection and prevention.

[20]  G. Colditz,et al.  Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  A. Ziogas,et al.  Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. , 2004, Journal of the National Cancer Institute.

[22]  A. Hofman,et al.  Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. , 2003, Human molecular genetics.

[23]  Diederick E Grobbee,et al.  NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. , 2003, Pharmacogenetics.

[24]  S. Humphries,et al.  Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. , 2003, The Journal of clinical endocrinology and metabolism.

[25]  N. Le,et al.  Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer , 2002, The Lancet.

[26]  Thomas E Rohan,et al.  Cigarette smoking and the risk of breast cancer in women: a review of the literature. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  J. Chang-Claude,et al.  Active and passive smoking and risk of breast cancer by age 50 years among German women. , 2002, American journal of epidemiology.

[28]  Jenny Chang-Claude,et al.  Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  J. Manson,et al.  Relation between markers of systemic vascular inflammation and smoking in women. , 2002, The American journal of cardiology.

[30]  W. Willett,et al.  Active and Passive Smoking in Breast Cancer: Prospective Results from the Nurses’ Health Study , 2002, Epidemiology.

[31]  Manal M. Hassan,et al.  Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. , 2002, Carcinogenesis.

[32]  A. Morabia.  Smoking (active and passive) and breast cancer: Epidemiologic evidence up to June 2001 , 2002, Environmental and molecular mutagenesis.

[33]  T. Lash,et al.  Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. , 2002, Pharmacogenetics.

[34]  G. Berglund,et al.  Smoking associated with hormone receptor negative breast cancer , 2001, International journal of cancer.

[35]  B E Ainsworth,et al.  Compendium of physical activities: an update of activity codes and MET intensities. , 2000, Medicine and science in sports and exercise.

[36]  M. Brandi,et al.  Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. , 2000, Human molecular genetics.

[37]  J. S. Gim,et al.  Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. , 2000, Pharmacogenetics.

[38]  Chen-Yang Shen,et al.  Association between N‐acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post‐menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence , 1999, International journal of cancer.

[39]  B E Ainsworth,et al.  Moderate physical activity patterns of minority women: the Cross-Cultural Activity Participation Study. , 1999, Journal of women's health & gender-based medicine.

[40]  M. Bernstein,et al.  Re: Hunter, D.J., Hankinson, S.E., Hough, H. et al. (1997), A prospective study of NAT2 acetylation genotype, cigarette smoking and risk of breast cancer. Carcinogenesis, 18, 2127-2132. , 1998, Carcinogenesis.

[41]  J. Manson,et al.  A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. , 1997, Carcinogenesis.

[42]  L. Kuller,et al.  Determinants of premenopausal bone mineral density: The interplay of genetic and lifestyle factors , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  Word Dl,et al.  Building a Spanish surname list for the 1990s--a new approach to an old problem. , 1996 .

[44]  J. Russo,et al.  Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis , 1983, Environmental health perspectives.

[45]  J. Samet,et al.  Survey research in New Mexico Hispanics: some methodological issues. , 1983, American journal of epidemiology.

[46]  C. Maack,et al.  Mutagenic activity in nipple aspirates of human breast fluid. , 1980, Cancer research.